Justification of AUC0-72 usage and AP calculation [Regulatives / Guidelines]

posted by mittyri  – Russia, 2014-06-10 22:05 (4403 d 20:51 ago) – Posting: # 13053
Views: 3,413

Dear All,

According to the EU GL
AUC truncated at 72 h (AUC(0-72h)) may be used as an alternative to AUC(0-t) for comparison of extent of exposure as the absorption phase has been covered by 72 h for immediate release formulations.

Do we need to put in the Protocol any justification about "the absorption phase has been covered by 72 h"?

Could you help with Absorption Phase calculation from literature data? I've found only a simple method
AP<2-4×tmax
(from Helmut's Lecture :-D)

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
330 visitors (0 registered, 330 guests [including 14 identified bots]).
Forum time: 18:57 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5